SRRK

49.0252.67%
RK

Robert Keith Woods

Chief Operating Officer

Mr. Robert Keith Woods is Chief Operating Officer of Scholar Rock Holding Corporation from April 2025. Mr. Woods serves as an Independent Director at Neurogene Inc. since December 18, 2023. He served as Independent Non- Executive Director of Rocket Pharmaceuticals, Inc. since December 2023 until 2025. He serves as an Independent Director of TScan Therapeutics, Inc. since December 2023. He was Independent Director at X4 Pharmaceuticals, Inc. since October 16, 2023 until August 22, 2025. He served as Member of Board Advisors at argenx SE since March 2023 until June 2025 and had been its Chief Operating Officer since April 05, 2018 until March 13, 2023. Mr. Woods has many years of experience in the biopharmaceutical industry. Mr. Woods previously served in a variety of roles at Alexion Pharmaceuticals, including Vice President and Managing Director of Alexion UK, overseeing all aspects of Alexion’s UK business and Vice President, U.S. Commercial Operations, ending his tenure there as Senior Vice President of North America Business Operations. Within Alexion, he previously served as Vice President and Managing Director of Alexion UK, overseeing all aspects of Alexion's U.K. business; Vice President of U.S. Operations; and Executive Director of Sales, leading the launch of Soliris in atypical hemolytic uremic syndrome. Prior to joining Alexion, he held various positions of increasing responsibility within Roche, Amgen and Eisai. Mr. Woods holds a B.S. in Marketing from Florida State University.

Positions